These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10516376)

  • 21. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron requirements in hemodialysis.
    Sargent JA; Acchiardo SR
    Blood Purif; 2004; 22(1):112-23. PubMed ID: 14732819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The systemic inflammatory response and its impact on iron nutriture in end-stage renal disease.
    Bistrian BR; Khaodhiar L
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S35-9. PubMed ID: 10516374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iron story: red smoke and magnetism?
    Wish JB
    Nephrol News Issues; 2014 Feb; 28(2):2-3. PubMed ID: 24649743
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection.
    Brewster UC; Coca SG; Reilly RF; Perazella MA
    Nephrology (Carlton); 2005 Apr; 10(2):124-8. PubMed ID: 15877670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE; Peat N; Porter C; Morgan AG
    Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R; Kalantar-Zadeh K
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of iron in patients on chronic dialysis: mistake and misconceptions.
    Sakiewicz P; Paganini E
    J Nephrol; 1998; 11(1):5-15. PubMed ID: 9561479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Appropriate iron supplementation in renal anemia treatment].
    Suzuki M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():566-8. PubMed ID: 15250370
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron therapy in end-stage renal disease.
    Brewster UC
    Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients.
    Pollak VE; Lorch JA; Means RT
    J Investig Med; 2001 Mar; 49(2):173-83. PubMed ID: 11288758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic effects of IV iron preparations in CKD patients.
    Vaziri ND
    Nephrol News Issues; 2014 Feb; 28(2):4-5. PubMed ID: 24649744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
    Markowitz GS; Kahn GA; Feingold RE; Coco M; Lynn RI
    Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of early utilization of intravenous iron.
    Vogel S
    Nephrol Nurs J; 2000 Feb; 27(1):61-5. PubMed ID: 10852693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IV Iron: To Give or to Hold in the Presence of Infection in Adults Undergoing Hemodialysis.
    Hain D; Braun M
    Nephrol Nurs J; 2015; 42(3):279-83; quiz 284. PubMed ID: 26207288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.